B-type natriuretic peptide at admission is a predictor of all-cause mortality at one year after the first acute episode of new-onset heart failure with preserved ejection fraction

HIGHLIGHTS

  • who: Liviu-Nicolae Ghilencea et al. from the Department of Cardiology, Elias University Hospital, Carol Davila University of Medicine and Pharmacy have published the research work: B-Type Natriuretic Peptide at Admission Is a Predictor of All-Cause Mortality at One Year after the First Acute Episode of New-Onset Heart Failure with Preserved Ejection Fraction, in the Journal: (JOURNAL)
  • what: This study aimed to assess the ability of NT-proBNP at admission to predict mortality risk at one year in patients with a first acute episode of new-onset HFpEF, and to subsequently identify . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?